Total Funding
81
62
Total FundingGrant raised
Growth Score 81 in past quarter
-9 pts
Heat Score 62 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
62896
XingImaging is a CRO service provider of nuclear drug transformation and clinical trial imaging.
Acquired by 
Yantai Dongcheng Pharmaceutical
MITRO Biotech
About the Company
XingImaging, LLC is a clinical PET imaging service company anchored in China and specializing in Radiotracer Production through Positron Emission Tomography (PET) acquisition to evaluate, and support development of treatments for neurodegenerative disorders including Alzheimer and Parkinson disease, Oncology and other disease pathologies.
